CLMT 8-K 2026-11-06
Calumet, Inc. /DE (CLMT) 8-K dated 2026-11-06 — accession 0002013745-26-000032.
Calumet, Inc. /DE (CLMT) is a specialty chemicals company listed on NASDAQ.
CLMT to acquire platform ($265M)
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CLMT revenue for 2025-12-31 was $4.14B. Net income was -$33.8M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. CLMT currently screens at market cap $2.89B.
Not investment advice. The CLMT SEC hub lists recent forms. The stock page is the research view.
- Guidance
- outlook,” “forecast,” “anticipate,” “estimate,” “continue,” “plan,” “should,” “could,” “would,” or other similar expressions ar
- Deal
- $265M
Why it matters
- outlook,” “forecast,” “anticipate,” “estimate,” “continue,” “plan,” “should,” “could,” “would,” or other similar expressions ar
- Transaction value about $265M
- The third quarter was exceptional for Calumet, with both of our businesses delivering outstanding results and our deleveraging and growth strategy accelerati…